Patients should contact their provider if they experience signs of hypoglycemia (confusion, sweating, tremor, rapid heartbeat), particularly if taking tirzepatide concurrently with insulin or sulfonylureas, as dose adjustments of these medications may be necessary
Injection site reactions are the most commonly reported dermatological adverse effects, occurring in approximately 1.2-1.4% of patients according to the Ozempic SmPC
By restoring that signaling with a medication like semaglutide, its hypothesized we can relieve pain and possibly reduce bloating
Same effect, half the price, no re-titration needed. Megan O
Because GLP-1 medications reduce appetite, some patients unintentionally eat too little or miss key nutrients